Showing results (621-630 of 794) with videos related to
Sort By:
Pageof 80
Journal of Medicinal Chemistry|January 1, 1978
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfateC J Barnett, G J Cullinan, K Gerzon, et al.Proceedings of the National Academy of Sciences of the United States of America|April 30, 2014
Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activationChen-Lin Hsieh, Teng Fei, Yiwen Chen, et al.Cancer Discovery|December 8, 2021
Atezolizumab Treatment of Tumors with High Tumor Mutational Burden from MyPathway, a Multicenter, Open-Label, Phase IIa Multiple Basket StudyClaire F Friedman, John D Hainsworth, Razelle Kurzrock, et al.The Breast Journal|March 12, 2021
Clinicopathological correlates, oncological impact, and validation of Oncotype DX™ in a European Tertiary Referral CentreMatthew G Davey, Éanna J Ryan, Sami Abd Elwahab, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2018
Quality of Life During Treatment With Chemohormonal Therapy: Analysis of E3805 Chemohormonal Androgen Ablation Randomized Trial in Prostate CancerAlicia K Morgans, Yu-Hui Chen, Christopher J Sweeney, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2015
Stress-Related Signaling Pathways in Lethal and Nonlethal Prostate CancerDonghao Lu, Jennifer A Sinnott, Unnur Valdimarsdóttir, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2007
Efficacy and safety of single-agent pertuzumab (rhuMAb 2C4), a human epidermal growth factor receptor dimerization inhibitor, in castration-resistant prostate cancer after progression from taxane-based therapyDavid B Agus, Christopher J Sweeney, Michael J Morris, et al.European Urology|April 22, 2023
PARP Inhibitors for Prostate Cancer: Tangled up in PROfound and PROpel (and TALAPRO-2) BluesNick Beije, Wassim Abida, Emmanuel S Antonarakis, et al.International Journal of Radiation Oncology, Biology, Physics|November 5, 2015
Definition and Validation of "Favorable High-Risk Prostate Cancer": Implications for Personalizing Treatment of Radiation-Managed PatientsVinayak Muralidhar, Ming-Hui Chen, Gally Reznor, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Two drug interaction studies evaluating the pharmacokinetics and toxicity of pemetrexed when coadministered with aspirin or Ibuprofen in patients with advanced cancerChristopher J Sweeney, Chris H Takimoto, Jane E Latz, et al.Pageof 80